艾隆科技：承接政策红利，开启成长新空间

Core Viewpoint - The joint issuance of the policy by nine departments aims to promote high-quality development in the pharmaceutical retail industry, focusing on various dimensions such as improving pharmaceutical services, innovating health services, and optimizing industry structure, which will inject strong momentum into the digital transformation of the sector [1][2] Group 1: Policy Impact - The policy mandates pharmaceutical retail enterprises to accurately collect and verify drug traceability codes during sales, enhancing drug traceability management and application, thereby improving medication safety supervision and risk control of medical insurance funds [1] - The policy emphasizes the need for digitalization and intensive transformation in the pharmaceutical retail industry, which is expected to release concentrated demand for these changes [2] Group 2: Company Positioning - Ailong Technology (688329.SH) is positioned to benefit from the policy due to its strong foundation in smart pharmacy, smart wards, smart storage, and pharmaceutical information, which allows it to fully leverage the policy dividends and open up new growth spaces [1] - The company has developed the "Drug 4π All-Dimensional Spherical Scanning System," which achieves comprehensive recognition of traceability codes and meets the upgraded traceability management needs of retail pharmacies, already receiving high recognition in practical use [1] - Ailong Technology has established a comprehensive scene system covering material management within hospitals, achieving domestic substitution of core equipment and reaching international leading technical standards, thus forming a complete product line from single products to overall solutions [2] Group 3: Market Potential - The company's full series of dispensing machines align precisely with the policy's requirements for traceability management, enabling automatic collection and association of traceability code information during prescription dispensing, thus creating a new paradigm of unmanned traceability code collection in the industry [2] - The products and services of Ailong Technology have been validated by over a thousand medical institutions, indicating significant potential for expansion in the retail sector as the policy details gradually take effect [2] - With its first-mover advantage, the company is expected to capture market share and enhance its performance growth momentum as the policy is implemented [2]